A detailed history of Andra Ap Fonden transactions in Eli Lilly & CO stock. As of the latest transaction made, Andra Ap Fonden holds 57,600 shares of LLY stock, worth $46.1 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares
57,600
Previous 63,300 9.0%
Holding current value
$46.1 Million
Previous $57.3 Million 10.96%
% of portfolio
0.77%
Previous 0.97%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$772.14 - $960.02 $4.4 Million - $5.47 Million
-5,700 Reduced 9.0%
57,600 $51 Million
Q2 2024

Aug 07, 2024

BUY
$724.87 - $909.04 $15.9 Million - $19.9 Million
21,900 Added 52.9%
63,300 $57.3 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $24.5 Million - $32.8 Million
41,400 New
41,400 $32.2 Million
Q2 2023

Aug 09, 2023

SELL
$350.74 - $468.98 $4.07 Million - $5.44 Million
-11,600 Reduced 34.32%
22,200 $10.4 Million
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $1.37 Million - $1.61 Million
-4,400 Reduced 11.52%
33,800 $11.6 Million
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $4.63 Million - $5.4 Million
-14,400 Reduced 27.38%
38,200 $14 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $948,736 - $1.08 Million
3,200 Added 6.48%
52,600 $17 Million
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $919,809 - $1.08 Million
3,300 Added 7.16%
49,400 $16 Million
Q4 2021

Feb 15, 2022

SELL
$224.85 - $279.04 $2.72 Million - $3.38 Million
-12,100 Reduced 20.79%
46,100 $12.7 Million
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $332,400 - $409,064
1,500 Added 2.65%
58,200 $13.4 Million
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $144,440 - $186,832
800 Added 1.43%
56,700 $13 Million
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $788,736 - $1.02 Million
4,800 Added 9.39%
55,900 $10.4 Million
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $1.75 Million - $2.31 Million
-13,400 Reduced 20.78%
51,100 $8.63 Million
Q3 2020

Nov 12, 2020

SELL
$146.22 - $169.13 $1.84 Million - $2.13 Million
-12,600 Reduced 16.34%
64,500 $9.55 Million
Q2 2020

Aug 06, 2020

BUY
$136.42 - $164.18 $2.02 Million - $2.43 Million
14,800 Added 23.76%
77,100 $12.7 Million
Q1 2020

May 13, 2020

BUY
$119.05 - $147.35 $1.83 Million - $2.27 Million
15,400 Added 32.84%
62,300 $8.64 Million
Q4 2019

Feb 10, 2020

SELL
$106.92 - $132.43 $502,524 - $622,421
-4,700 Reduced 9.11%
46,900 $6.16 Million
Q3 2019

Nov 19, 2019

SELL
$106.79 - $116.16 $448,518 - $487,872
-4,200 Reduced 7.53%
51,600 $5.77 Million
Q2 2019

Aug 15, 2019

BUY
$110.79 - $129.32 $400,284 - $467,233
3,613 Added 6.92%
55,800 $6.18 Million
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $5.75 Million - $6.76 Million
-51,613 Reduced 49.72%
52,187 $6.77 Million
Q3 2018

Oct 16, 2018

BUY
$85.86 - $107.31 $2.28 Million - $2.84 Million
26,500 Added 34.28%
103,800 $11.1 Million
Q2 2018

Aug 17, 2018

SELL
$75.7 - $86.88 $1.04 Million - $1.2 Million
-13,800 Reduced 15.15%
77,300 $6.6 Million
Q1 2018

Apr 10, 2018

SELL
$74.21 - $87.6 $10.4 Million - $12.3 Million
-140,807 Reduced 60.72%
91,100 $7.05 Million
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $533,183 - $571,900
6,507 Added 2.89%
231,907 $19.6 Million
Q3 2017

Oct 31, 2017

BUY
$77.07 - $85.54 $17.4 Million - $19.3 Million
225,400
225,400 $19.3 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $760B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Andra Ap Fonden Portfolio

Follow Andra Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.